Skip to main content
Clinical Trials/ISRCTN17197337
ISRCTN17197337
Active, not recruiting
未知

Influence of new implant surface decontamination method (Galvosurge®) in the surgical reconstructive treatment of peri-implant related intrabony defects

Arrow Development S.L.0 sites40 target enrollmentJanuary 16, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Removal of the attached biofilm and calculus from dental implant surface
Sponsor
Arrow Development S.L.
Enrollment
40
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2023
End Date
December 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Arrow Development S.L.

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \= 18 years
  • 2\. Peri\-implant bone defect \=3 mm assessed radiographically
  • 3\. Peri\-implant pocket depth (PPD) \=5 mm combined with bleeding on probing or suppuration
  • 4\. Intra\-surgically, bone defect must have at least an intraosseous component of 3 mm and a width of no more than 4mm
  • 5\. Implants \=1 year in function

Exclusion Criteria

  • 1\. Treated for peri\-implantitis during the previous 6 months
  • 2\. Intake of systemic or local antibiotics during the previous 6 months
  • 3\. Pregnant patients
  • 4\. Systemically unhealthy patients
  • 5\. Patients allergic to collagen

Outcomes

Primary Outcomes

Not specified

Similar Trials